Phase II study of radiochemotherapy for elderly patients with oesophagus cancer.
Phase II study of radiochemotherapy for elderly patients with oesophagus cancer with Radiotherapy = 50 Gy, 2Gy/f ans chemotherapy with 2 arms arm Cisplatin = Cisplatin 75mg/m2 J1J22 or arm Oxaliplatine = oxaliplatine 85mg/m2 every 2 weeks.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
23
Arm cisplatin : 75mg/m2, day n\*1 and day n\*22, And radiotherapy 50 Gy, 2Gy/f
85 mg/m2 every 2 weeks, 6 times And radiotherapy 50 Gy, 2Gy/f
Feasibility of treatment: Number of patients with completed treatment
number of patient with completed treatment
Time frame: 6 weeks after end of the radiochemotherapy
Tumoral response
tumoral evaluation at 6 weeks after the treatment
Time frame: 6 weeks after end of the radiochemotherapy
Quality of life
QLQC30
Time frame: 6 weeks after end of the radiochemotherapy
Quality of life
ELD14
Time frame: 6 weeks after end of the radiochemotherapy
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.